Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
47.05B
Market cap47.05B
Price-Earnings ratio
45.00
Price-Earnings ratio45.00
Dividend yield
Dividend yield
Average volume
5.56M
Average volume5.56M
High today
$83.00
High today$83.00
Low today
$83.00
Low today$83.00
Open price
$81.31
Open price$81.31
Volume
3.68K
Volume3.68K
52 Week high
$87.89
52 Week high$87.89
52 Week low
$72.30
52 Week low$72.30

Stock Snapshot

The current Edwards Lifesciences(EW) stock price is $83.00, with a market capitalization of 47.05B. The stock trades at a price-to-earnings (P/E) ratio of 45.00.

On 2026-04-24, Edwards Lifesciences(EW) stock moved within a range of $83.00 to $83.00. With shares now at $83.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 3.68K, compared to an average daily volume of 5.56M.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $72.30.

Over the past 52 weeks, Edwards Lifesciences(EW) stock has traded between a high of $87.89 and a low of $72.30.

EW News

TipRanks 17m
Edwards Lifesciences price target raised to $93 from $92 at Evercore ISI

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Edwards Lifesciences (EW) to $93 from $92 and keeps an Outperform rating on the shares. Unlo...

Nasdaq 16h
Edwards Lifesciences Corp. Q1 Income Rises

(RTTNews) - Edwards Lifesciences Corp. (EW) released a profit for its first quarter that Increases, from the same period last year The company's earnings came...

Edwards Lifesciences Corp. Q1 Income Rises
Simply Wall St 2d
How Edwards' TAVR and TMTT Momentum Heading Into Q1 2026 Has Changed Its Investment Story

Edwards Lifesciences recently guided investor expectations ahead of its first-quarter 2026 earnings release on April 23, highlighting momentum across key struct...

How Edwards' TAVR and TMTT Momentum Heading Into Q1 2026 Has Changed Its Investment Story

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
25%
Sell
0%

More EW News

Simply Wall St 7d
Is Edwards Lifesciences Fairly Priced After Recent Share Price Moves?

If you are wondering whether Edwards Lifesciences at around US$80.99 is a fair deal or a stretched price, the starting point is understanding how its current ma...

Is Edwards Lifesciences Fairly Priced After Recent Share Price Moves?

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.